Trial
NCT02713984
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Zhi Yang
Collaborators
—
Condition
Breast Cancer
Intervention
Anti-HER2 CAR-T
Why stopped
Reform CAR structure due to safety consideration
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-19